🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
Some patients with low-level viremia (LLV) are also likely to develop hepat...
Status
Unknown
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2023-08-15
Trial ID
NCT05991531
After LT, long-term immunosuppressive therapy is required to prevent organ ...
Status
Unknown
Location
The University of Hong Kong
Start Date
2022-01-01
Trial ID
NCT04199819
Treatments Being Tested
The hepatitis C virus is a major cause of chronic liver diseases, including...
Status
Unknown
Location
Multiple Locations
Start Date
2019-01
Trial ID
NCT03687229
Currently, there is a lack of literature on programs evaluating rapid scree...
Status
Unknown
Location
Toronto General Hospital
Start Date
2024-02-01
Trial ID
NCT04620226
Treatments Being Tested
This prospective cohort study aims to constitute a 500-participant database...
Status
Recruiting
Location
CHU de Montpellier - CIMA
Start Date
2026-06-23
Trial ID
NCT07515638
Treatments Being Tested
As an alternative biomarker of intrahepatic covalently closed circular DNA(...
Status
Completed
Location
Multiple Locations
Start Date
2016-02-01
Trial ID
NCT03909191
Treatments Being Tested
This retrospective study will evaluate the association of biomarkers and th...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01705704
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low...
Status
Unknown
Location
Sohag University
Start Date
2022-05-01
Trial ID
NCT05371743
Our research team has executed a robust strategy to improve viral hepatitis...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-20
Trial ID
NCT06539052
Treatments Being Tested